Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.
Autorzy:
Cabezón M; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Badalona, Spain. Malinverni R; Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukemia Research Institute (IJC), Campus ICO-GTP-UAB, Badalona, Spain. Bargay J; Hematology Service, Hospital Son Llàtzer, Palma de Mallorca, Spain. Xicoy B; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Badalona, Spain. Marcé S; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain. Garrido A; Hematology Service, Hospital de Sant Pau, Barcelona, Spain. Tormo M; Hematology Service, Hospital Clínico de Valencia, Valencia, Spain. Arenillas L; Hematology Service, Hospital del Mar, Barcelona, Spain. Coll R; Hematology Service, ICO Girona - Hospital Josep Trueta, Girona, Spain. Borras J; Hematology Service, Hospital Son Llàtzer, Palma de Mallorca, Spain. Jiménez MJ; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain. Hoyos M; Hematology Service, Hospital de Sant Pau, Barcelona, Spain. Valcárcel D; Hematology Service, Hospital Vall D'Hebron, Barcelona, Spain. Escoda L; Hematology Service, Hospital Joan XXIII, Tarragona, Spain. Vall-Llovera F; Hematology Service, Hospital Mútua de Terrassa, Terrassa, Spain. Garcia A; Hematology Service, Hospital Arnau de Vilanova, Lleida, Spain. Font LL; Hematology Service, Hospital Verge de La Cinta, Tortosa, Spain. Rámila E; Hematology Service, Hospital Parc Taulí, Sabadell, Spain. Buschbeck M; Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukemia Research Institute (IJC), Campus ICO-GTP-UAB, Badalona, Spain.; Program for Predictive and Personalized Medicine of Cancer, Germans Trias I Pujol Research Institute (PMPPC-IGTP), Badalona, Spain. Zamora L; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain. .
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies